| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/13/2006 | US7060298 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059764A2 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 06/08/2006 | WO2006058546A1 Novel lactame derivatives as renin inhibitors |
| 06/08/2006 | WO2006035280A8 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 06/08/2006 | WO2006013420B1 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 06/08/2006 | WO2006010503A3 Rxr antagonists in the treatment of inflammatory diseases |
| 06/08/2006 | US20060122411 Chloride channel opener |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122275 Agentfor reducing side effects of diclofenac |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122244 Hypoglycemic agents; antidiabetic agentys; side effect reduction; cardiovascular disorders; anticancer agents |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122170 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121129 Dietary supplement |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121088 delivering to an external portion of the body passageway a therapeutic agent such as an antiangiogenic factor from a thread; treating stenosis or restenosis for example |
| 06/08/2006 | US20060121029 Method and composition for regulating the activity of regulatory t cells |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2584136A1 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666067A1 Drug containing chymase inhibitor as the active ingredient |
| 06/07/2006 | EP1663983A1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 06/07/2006 | EP1663397A1 Injectable therapeutic formulations |
| 06/07/2006 | EP1663250A1 Methods for treating bladder dysfunction |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1369416B1 Stable crystals of pyrrole compound |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1334367B1 A method of determining the initial dose of vitamin d compounds |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1104307B1 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/07/2006 | CN1784397A Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
| 06/07/2006 | CN1784235A Fortifier |
| 06/07/2006 | CN1784223A Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781910A Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 06/07/2006 | CN1781538A Chinese medicine preparation for treating mephritis and nephrosis syndrome |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056922 Acylamino cyclopropane derivatives |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056910 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056655 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006057346A1 Ameliorant for renal insufficiency |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2005118537A3 Arylpiperazine derivatives as adrenergic receptor antagonists |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116505 Glucose and/or fructose transporter naglt1 and its gene |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116339 Antisense modulation of purinoreceptor p2x3 |
| 06/01/2006 | US20060115540 administering (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide; treating urogenital disorders |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 05/31/2006 | EP1661574A1 Beta-hydroxy short to medium chain fatty acid polymer |
| 05/31/2006 | EP1660494A2 Thiazoles as inhibitors of the alk-5 receptor |
| 05/31/2006 | EP1660484A1 Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1660104A1 Pharmaceutical formulation comprising lanthanum compounds |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1659970A1 Sytem and method for prevention of radiocontrast induced nephropathy |
| 05/31/2006 | EP1448181B1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1413305B1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | EP0839040B1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 05/31/2006 | CN1780840A Pyrazolo 1,5-a pyrimidine derivatives |
| 05/31/2006 | CN1780838A Azabicyclononene derivatives |
| 05/31/2006 | CN1780836A Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 05/31/2006 | CN1780819A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 05/31/2006 | CN1780634A Methods and compositions using gonadotropin hormone releasing hormone |
| 05/31/2006 | CN1780617A Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 05/31/2006 | CN1778364A Colloidal ball for detoxication and anodyne |
| 05/31/2006 | CN1778357A Medicine for treating urine retention of prostate and its preparation |
| 05/31/2006 | CN1257969C Polygonum capilalum extract , its preparation method and use |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257740C Preparation of pure Chinese traditional medicine for curing acute nephritis and chronic nephritis |
| 05/31/2006 | CN1257739C Senshitong mixture |
| 05/30/2006 | US7053228 Cushing disease; antidepressant; modulate immunology response |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |